Limited Capacity in US Pediatric Drug Trials: Qualitative Analysis of Expert Interviews

Author： Wasserman Richard Bocian Alison Harris Donna Slora Eric

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.2, 2011-04, pp. : 119-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using multiple coders to enhance qualitative analysis: The case of interviews with consumers of drug treatment

By Berends Lynda Johnston Jennifer

Addiction Research and Theory, Vol. 13, Iss. 4, 2005-08 ,pp. : 373-381

Informa Healthcare

Access to resources Recommend Favorite

Investigator barriers and preferences to conduct clinical drug trials in Finland: a qualitative study

By Keinonen T. Keränen T. Klaukka T. Saano V. Ylitalo P. Enlund H.

Pharmacy World and Science, Vol. 25, Iss. 6, 2003-12 ,pp. : 251-259

Springer Publishing Company

Access to resources Recommend Favorite

Ethical Issues in Including Pediatric Cancer Patients in Drug Development Trials

By Aleksa K.

Pediatric Drugs, Vol. 4, Iss. 4, 2002-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Published Pediatric Randomized Drug Trials in Developing Countries, 1996-2002

By Aripin Khairun N.B. Nor Sammons Helen M. Choonara Imti

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 99-103

Adis International

Access to resources Recommend Favorite

Limited publication of paediatric exclusivity trials

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite